ISSN: 2332-0877

Revista de terapia y enfermedades infecciosas

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Clinical Differences between Methicillin-Resistant and -Susceptible Staphylococcus aureus Bacteremia in Adult Patients at a Tertiary Hospital in Japan

Yuji Watanabe, Kazuki Takano, Maya Hariu, Yasuhiro Kamioka, Daishi Shimada, Haruka Imai, Katsuhiro Fuse and Masafumi Seki

To determine clinical differences in features of methicillin-susceptible and resistant Staphylococcus aureus (MSSA and MRSA, respectively) bacteremia, 15 adult patients with MRSA bacteremia were compared with 30 adult patients with MSSA bacteremia who were hospitalized during 2015 – 2018.

Compared with MSSA bacteremia patients, MRSA bacteremia patients had a higher age (mean age, 82.0 years and 72.5 years, respectively) and were more likely to have diabetes mellitus significantly (p=0.04). Liver and kidney functions were also significantly decreased in MRSA bacteremia patients compared with MSSA bacteremia patients (p=0.037, p=0.001 and p=0,015, respectively). Moreover, MRSA bacteremia patients showed a much higher mortality rate than MSSA bacteremia patients (60% and 20%, respectively; odds ratio: 2.66, 95% CI; 1.806-4.288, p=0.007).

These data suggest that MRSA bacteremia is more lethal than MSSA bacteremia in adults. Thus, caution should be taken when Staphylococcus aureus is isolated from the blood of patients who are elderly, diabetic, or have liver and kidney dysfunction because MRSA can be more possible pathogens rather than MSSA.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.